Similarly, in one study, interferon-gamma release assays such as quantiferon TB gold showed a negative result in 28.8% of patients with extrapulmonary tuberculosis, with sensitivity further being affected by HIV status, diabetes mellitus, neutropenia, immunosuppression, and severe TB disease [14]. The gene discussed is IFNG; the disease is tuberculosis.